Polymeric anticancer drugs with pH-controlled activation.
about
Killing cancer cells by targeted drug-carrying phage nanomedicinesDevelopment of polymeric micelles for targeting intractable cancersStrategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer TherapeuticsPhotodynamic therapy: one step ahead with self-assembled nanoparticlesInteractions of nanomaterials and biological systems: Implications to personalized nanomedicineFabrication and intracellular delivery of doxorubicin/carbonate apatite nanocomposites: effect on growth retardation of established colon tumorPoly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel deliveryPreparation and in vivo evaluation of radioiodinated closo-decaborate(2-) derivatives to identify structural components that provide low retention in tissues.Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.Stimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammationMacromolecular therapeuticsPolymer-Based TherapeuticsPhotoregulated release of caged anticancer drugs from gold nanoparticles.A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas.Functional virus-based polymer-protein nanoparticles by atom transfer radical polymerization.Immunotoxins and anticancer drug conjugate assemblies: the role of the linkage between components.Folic acid targeted Mn:ZnS quantum dots for theranostic applications of cancer cell imaging and therapy.pH- and NIR Light-Responsive Polymeric Prodrug Micelles for Hyperthermia-Assisted Site-Specific Chemotherapy to Reverse Drug Resistance in Cancer Treatment.One-component nanomedicineChemotherapeutic evaluation of a synthetic tubulysin analogue-dendrimer conjugate in c26 tumor bearing miceNanoscale polymer carriers to deliver chemotherapeutic agents to tumours.Visible-light-sensitive titanium dioxide nanoplatform for tumor-responsive Fe2+ liberating and artemisinin delivery.POLYMERIC BIOMATERIALS AND NANOMEDICINES.DNA-based delivery vehicles: pH-controlled disassembly and cargo release.Polymer conjugates as anticancer nanomedicines.pH-dependent, thermosensitive polymeric nanocarriers for drug delivery to solid tumors.Synthesis and characterization of bioactive tamoxifen-conjugated polymers.Polymeric Nanomedicines Based on Poly(lactide) and Poly(lactide-co-glycolide).Advances of cancer therapy by nanotechnology.Chain-shattering polymeric therapeutics with on-demand drug-release capabilityBiodegradable amphiphilic polymer-drug conjugate micelles.DNA-based applications in nanobiotechnologyMacromolecules as taxane delivery systems.The use of reversible addition fragmentation chain transfer polymerization for drug delivery systems.Molecular tweezers: concepts and applications.Click chemistry with polymers, dendrimers, and hydrogels for drug delivery.Acid-degradable polymers for drug delivery: a decade of innovation.Effects of light-activated diazido-PtIV complexes on cancer cells in vitro.Smart chemistry in polymeric nanomedicine.Ceramic nanoparticles: Recompense, cellular uptake and toxicity concerns.
P2860
Q21256651-026848CE-E1C1-4F8A-9C7E-E4C4A36ADE38Q26749611-FFBFDD00-6769-439F-9199-B50084969350Q26780335-42293ADF-B8E5-4CA1-B8C7-B6A5114DAE6EQ28083513-E1666072-F7D9-4FD7-A0E7-15729852F9DFQ28391849-590C1E2D-7E5E-4911-AA0E-076A618BA60BQ28486235-D25247F1-ACF2-41CA-948C-CBF799415078Q30664584-EFFE4007-B892-4723-9050-FCD844A849D1Q33657227-295EBBA8-DA6D-435E-B227-A17CF5DD5423Q33684453-6A47CB5E-82FA-4095-9FC9-C6431C949C20Q33708080-1F1BAB90-CFCE-40F3-A525-4B63FE08F543Q34079574-A0FB2A25-48C0-4A28-BB1D-96D49CE1687BQ34781736-91EC59CD-01CD-44FB-8104-94F71A585B19Q34974579-B8953601-D723-4F0C-9EA6-1B95AEB0D935Q35130646-AC1AFC28-EBC8-44B2-9D1B-B328B1735BC1Q35184737-891480AF-7106-4D3C-A609-C8A06BA08918Q35459059-CA40A8C9-2958-405F-B264-E17CAA656FC8Q35917899-0A5259B3-FA5B-486D-BC4B-C792499A505EQ35979399-FD7B66FE-CB26-4729-AEE6-325D33C57722Q36307689-51C0D34B-C294-4DF7-A9E2-5D0CB5EAD3DDQ36315671-8BCDE41A-0D62-42E7-95C0-C8953F0AAFDAQ36327049-A6670916-F1E0-49B1-A206-324154746F00Q36375792-2C75F1DB-28D6-4C52-B84C-67538A760EE9Q36376467-E4E15FEC-4751-4C99-99AA-7432C9C8BDC5Q36427803-75708200-BC60-41A5-9680-534EEEAD210AQ36561667-FF71ED2A-AF4F-4ECD-8787-027981F44CFDQ36750790-DDBE831F-51F7-4C56-ADCB-BB9C25AE264BQ36859343-9A394F5B-A021-475B-8411-0A1FD18491F8Q37056787-C237ECB6-0D44-4AB4-A068-DF84AE458479Q37234202-9AD27562-D86D-4B58-8E47-799B042FD11CQ37240107-A1341E96-086C-4C54-AE1F-8BDDE84F3783Q37567846-3B098111-A4B1-4265-8B10-9A6700CFDD8BQ37774876-EFCFFEF0-061D-4612-9533-C5273CDB3497Q37818236-666FF266-191D-4F61-A6B9-CD03A80F8199Q37830703-48BFD4D1-4185-4BB3-BBDA-A3293F520B2DQ37858487-0F854EFD-F0AD-412F-B453-51E7DA33ADFCQ37978480-B3BD8385-E6C0-4791-9E14-B41FCF53907EQ38074172-4A4EF752-B5B7-4582-9222-4B4132EF6D42Q38115290-1D18E799-9CE1-408A-B1C8-473E4F36337FQ38221776-993669DA-05F0-40A7-AF90-9A718653F262Q38250374-826BDCB9-9785-4F85-9F94-37DCDA271E5E
P2860
Polymeric anticancer drugs with pH-controlled activation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Polymeric anticancer drugs with pH-controlled activation.
@ast
Polymeric anticancer drugs with pH-controlled activation.
@en
type
label
Polymeric anticancer drugs with pH-controlled activation.
@ast
Polymeric anticancer drugs with pH-controlled activation.
@en
prefLabel
Polymeric anticancer drugs with pH-controlled activation.
@ast
Polymeric anticancer drugs with pH-controlled activation.
@en
P1476
Polymeric anticancer drugs with pH-controlled activation.
@en
P2093
Vladimír Subr
P304
P356
10.1016/J.ADDR.2003.10.040
P407
P577
2004-04-01T00:00:00Z